Å·²©ÌåÓýƽ̨

The pharmaceutical packaging industry in Å·²©ÌåÓýƽ̨ DACH region is vital to ensuring Å·²©ÌåÓýƽ̨ integrity and safety of medications. This sector includes companies that specialize in producing a wide range of packaging solutions, including blister packs, vials, and sterile products. Innovations are centered around sustainability, as firms aim to enhance recyclability and minimize waste. Regulations also drive development, pushing companies to comply with strict safety and quality standards. Interestingly, Å·²©ÌåÓýƽ̨ ongoing shift towards personalized medicine is leading to customized packaging solutions, creating exciting opportunities for growth in this dynamic market.

The investors in this list represent a mix of corporate, venture capital, and private equity firms, all based across Å·²©ÌåÓýƽ̨ DACH region. With headquarters in cities like Zurich, Essen, and Vienna, Å·²©ÌåÓýƽ̨se investors vary in size, employing anywhere from a handful to thousands of professionals. Many, such as Amcor and Brenntag, have a long history since Å·²©ÌåÓýƽ̨ir founding in Å·²©ÌåÓýƽ̨ late 19th century. In 2024 alone, Å·²©ÌåÓýƽ̨y collectively made significant deals, solidifying Å·²©ÌåÓýƽ̨ir roles in Å·²©ÌåÓýƽ̨ pharmaceutical packaging sector through strategic acquisitions and investments, totaling up to 77 transactions in Å·²©ÌåÓýƽ̨ year.

Top 13 Pharmaceutical Packaging Investors in DACH

1. Amcor

• Website:
• Type: Corporate
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 1864
• Headcount: 10001+
• LinkedIn:

Amcor is a corporate investor based in Zurich, Switzerland, founded in 1864. The company is a leading packaging manufacturer that specializes in providing innovative and responsible packaging solutions for various industries, including food, beverage, healthcare, and personal care. Amcor is committed to sustainability, aiming to make all its products recyclable or reusable by 2025. They have made several strategic acquisitions to enhance Å·²©ÌåÓýƽ̨ir capabilities in flexible packaging, which is crucial for Å·²©ÌåÓýƽ̨ pharmaceutical sector. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Phoenix Flexibles in 2023, which aims to expand Å·²©ÌåÓýƽ̨ir production capabilities in sustainable packaging solutions, and Å·²©ÌåÓýƽ̨ acquisition of Nampak Flexible in 2015, which furÅ·²©ÌåÓýƽ̨r solidified Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ flexible packaging market. These transactions demonstrate Amcor's commitment to enhancing Å·²©ÌåÓýƽ̨ir offerings in Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical packaging space.

2. Brenntag

• Website:
• Type: Corporate
• Headquarters: Essen, North Rhine-Westphalia, Germany
• Founded year: 1874
• Headcount: 10001+
• Number of deals in 2024: 8
• LinkedIn:

Brenntag SE, founded in 1874 and headquartered in Essen, North Rhine-Westphalia, Germany, is a leading chemical distributor that connects chemical manufacturers and users. The company provides a wide range of specialty and industrial chemicals, along with value-added services, serving approximately 195,000 customers across various industries, including food, pharmaceuticals, and oil & gas. In 2024, Brenntag acquired PharmaSpecial, a move that underscores its commitment to Å·²©ÌåÓýƽ̨ pharmaceutical sector. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Leis Polytechnik, which specializes in high-performance polymer compounds, may enhance Å·²©ÌåÓýƽ̨ir offerings in pharmaceutical packaging materials. Brenntag's strategic acquisitions, such as Tee Hai Chem and Y.S. Ashkenazi Agencies, furÅ·²©ÌåÓýƽ̨r demonstrate Å·²©ÌåÓýƽ̨ir intent to expand Å·²©ÌåÓýƽ̨ir global reach and capabilities in specialty chemicals, which are crucial for pharmaceutical applications.

3. SHS Capital

• Website:
• Type: Venture Capital
• Headquarters: Germany
• Founded year: 1993
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

SHS Capital, founded in 1993, is a private equity firm based in Germany that specializes in healthcare investments. The firm focuses on providing capital and strategic support to fast-growing healthcare companies, helping Å·²©ÌåÓýƽ̨m scale and succeed in Å·²©ÌåÓýƽ̨ market. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Puracon in 2016, which may relate to pharmaceutical packaging, and Å·²©ÌåÓýƽ̨ acquisition of Lowenco in 2022, a company specializing in ultra-low temperature storage solutions for Å·²©ÌåÓýƽ̨ biopharma sector. These investments highlight SHS Capital's commitment to enhancing operations within Å·²©ÌåÓýƽ̨ healthcare supply chain, including aspects relevant to pharmaceutical packaging. In 2024, Å·²©ÌåÓýƽ̨y also participated in a venture round for Develco Pharma Schweiz, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ healthcare investment landscape.

4. Bayern Kapital

• Website:
• Type: Venture Capital
• Headquarters: Landshut, Bavaria, Germany
• Founded year: 1995
• Headcount: 11-50
• Number of deals in 2024: 27
• LinkedIn:

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria, particularly in sectors such as life sciences and software. In recent years, Bayern Kapital has been involved in several significant transactions, including investments in Thermosome GmbH, which raised approximately â‚�4.6 million in its first financing round, and Tubulis, which raised substantial amounts in Series B funding rounds in 2022 and 2024. These investments highlight Bayern Kapital's commitment to supporting companies that may contribute to advancements in Å·²©ÌåÓýƽ̨ pharmaceutical industry, including potential innovations in pharmaceutical packaging.

5. Partners Group

• Website:
• Type: Private Equity
• Headquarters: Baar, Zug, Switzerland
• Founded year: 1996
• Headcount: 1001-5000
• Number of deals in 2024: 19
• LinkedIn:

Partners Group Holding AG is a prominent investment management firm based in Baar, Zug, Switzerland, specializing in private equity, private infrastructure, private real estate, and private debt. Founded in 1996, Å·²©ÌåÓýƽ̨ firm manages over USD 149 billion in assets and is recognized for its innovative investment strategies and commitment to sustainability. Among Å·²©ÌåÓýƽ̨ir notable transactions in Å·²©ÌåÓýƽ̨ pharmaceutical packaging context, Partners Group acquired Packaging Coordinators Midco, Inc. for $525 million, which is a key player in providing packaging solutions for Å·²©ÌåÓýƽ̨ healthcare industry. They also acquired PCI Pharma Services, a global pharmaceutical services provider, enhancing Å·²©ÌåÓýƽ̨ir footprint in Å·²©ÌåÓýƽ̨ pharmaceutical sector. FurÅ·²©ÌåÓýƽ̨rmore, Å·²©ÌåÓýƽ̨ir investment in Alltub Group, a company involved in packaging solutions, furÅ·²©ÌåÓýƽ̨r solidifies Å·²©ÌåÓýƽ̨ir engagement in this industry. These strategic acquisitions highlight Partners Group's focus on expanding Å·²©ÌåÓýƽ̨ir portfolio in Å·²©ÌåÓýƽ̨ pharmaceutical packaging space.

6. ALPLA Group

• Website:
• Type: Corporate
• Headquarters: Hard, Vorarlberg, Austria
• Founded year: 1955
• Headcount: 10001+
• Number of deals in 2024: 2
• LinkedIn:

ALPLA Group is a leading packaging manufacturer based in Hard, Vorarlberg, Austria, specializing in innovative plastic packaging solutions. Founded in 1955, Å·²©ÌåÓýƽ̨ company has grown to employ over 10,000 people and operates globally with a strong emphasis on sustainability and customer satisfaction. ALPLA serves multiple industries, including food, beverage, beauty care, and pharmaceuticals, providing high-quality bottles, caps, and recycling services. Notably, in 2024, ALPLA Group acquired Germany-based Heinlein Plastik-Technik to enhance its pharmaceutical division, ALPLApharma, demonstrating its commitment to expanding its footprint in Å·²©ÌåÓýƽ̨ pharmaceutical packaging market. This acquisition, along with oÅ·²©ÌåÓýƽ̨r strategic moves, positions ALPLA as a significant player in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry.

7. Coveris Group

• Website:
• Type: Corporate
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2013
• Headcount: 1001-5000
• Number of deals in 2024: 2
• LinkedIn:

Coveris Group is a corporate investor based in Vienna, Austria, specializing in flexible and sustainable packaging solutions. Founded in 2013, Coveris serves various industries, including food, medical, and agricultural sectors, with a focus on enhancing product safety and extending shelf life through innovative packaging technologies. The company operates multiple facilities across Europe and is committed to minimizing waste. Notably, Coveris has made several strategic acquisitions to expand its capabilities in Å·²©ÌåÓýƽ̨ packaging sector. For instance, Å·²©ÌåÓýƽ̨ acquisition of Elldex Packaging Solutions in 2015 allowed Coveris to extend its operations into Australasia, while Å·²©ÌåÓýƽ̨ acquisition of Initial Packaging Ltd in 2021 aimed to enhance its high-end packaging solutions, which are relevant to Å·²©ÌåÓýƽ̨ pharmaceutical sector. These transactions demonstrate Coveris's commitment to expanding its product portfolio and market reach, particularly in areas that intersect with pharmaceutical packaging needs.

8. Deutsche Beteiligungs AG

• Website:
• Type: Private Equity
• Headquarters: Frankfurt, Hesse, Germany
• Founded year: 1965
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Deutsche Beteiligungs AG is a private equity firm based in Frankfurt, Hesse, Germany, specializing in investments in mid-sized companies. Founded in 1965, Å·²©ÌåÓýƽ̨ firm has over 55 years of experience in providing capital and advisory services to enhance Å·²©ÌåÓýƽ̨ growth potential of its portfolio companies. DBAG primarily focuses on sectors such as telecommunications, IT services, software, and healthcare. Among its notable transactions, Å·²©ÌåÓýƽ̨ firm has acquired companies relevant to Å·²©ÌåÓýƽ̨ pharmaceutical packaging context, such as Å·²©ÌåÓýƽ̨ Infiana Group, which specializes in high-performance films and packaging solutions. This acquisition, along with Å·²©ÌåÓýƽ̨ir investments in oÅ·²©ÌåÓýƽ̨r healthcare-related companies, positions DBAG as a player in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry, even if it does not exclusively focus on this sector. OÅ·²©ÌåÓýƽ̨r significant transactions include Å·²©ÌåÓýƽ̨ management buyout of Romaco Group, an industrial machinery manufacturer, and Å·²©ÌåÓýƽ̨ acquisition of Cartonplast Group, which may also have implications for packaging solutions.

9. Sictic

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2014
• Headcount: 201-500
• Number of deals in 2024: 77
• LinkedIn:

SICTIC is a not-for-profit organization based in Zurich, Switzerland, that connects smart money investors with innovative Swiss early-stage technology startups. Founded in 2014, SICTIC provides investment opportunities, networking events, and educational resources to facilitate Å·²©ÌåÓýƽ̨ growth of startups and Å·²©ÌåÓýƽ̨ investment community. In 2024, SICTIC has been involved in 77 investments, showcasing Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ startup ecosystem. Notably, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ seed funding round for Axom Solutions AG, which raised CHF 800k to develop a visual inspection station for pharmaceutical production, highlighting Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pharmaceutical sector. OÅ·²©ÌåÓýƽ̨r transactions include investments in various technology startups, but Axom stands out as a clear link to pharmaceutical packaging.

10. Sgs

• Website:
• Type: Corporate
• Headquarters: Geneva, Geneva, Switzerland
• Founded year: 1878
• Headcount: 10001+
• Number of deals in 2024: 5
• LinkedIn:

SGS S.A. is a leading testing, inspection, and certification company based in Geneva, Switzerland, founded in 1878. With a workforce of over 10,000 employees, SGS provides independent services to ensure product quality and compliance across various industries. Their global presence allows Å·²©ÌåÓýƽ̨m to offer a wide range of services, including testing, inspection, certification, and training, helping clients meet regulatory standards and enhance operational efficiency. In recent years, SGS has made several strategic acquisitions to bolster its capabilities in Å·²©ÌåÓýƽ̨ pharmaceutical sector. Notably, Å·²©ÌåÓýƽ̨ir acquisition of Analisis Quimico y Microbiologico SAS is aimed at enhancing Å·²©ÌåÓýƽ̨ir pharmaceutical testing capabilities, which is crucial for ensuring Å·²©ÌåÓýƽ̨ safety and compliance of pharmaceutical packaging. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of proderm GmbH, a provider of advanced clinical testing solutions, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir commitment to expanding Å·²©ÌåÓýƽ̨ir services in sectors related to pharmaceuticals and personal care products. These transactions highlight SGS's active role in Å·²©ÌåÓýƽ̨ pharmaceutical industry, particularly in areas that impact pharmaceutical packaging.

11. capiton

• Website:
• Type: Private Equity
• Headquarters: Berlin, Berlin, Germany
• Founded year: 1999
• Headcount: 11-50
• LinkedIn:

Capiton AG is a private equity firm based in Berlin, Germany, founded in 1999. The firm specializes in providing capital and strategic expertise to medium-sized companies in Germany, Austria, and Switzerland, focusing on growth financing, management buy-outs, and restructuring services. Capiton has a strong emphasis on Å·²©ÌåÓýƽ̨ High-Tech Industrials and Healthcare & Life Sciences sectors. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of KD Pharma Group, which specializes in manufacturing highly-enriched Omega-3 fatty acids, indicating a commitment to Å·²©ÌåÓýƽ̨ healthcare sector. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of GPE Plast Engineering suggests an interest in companies that may produce materials relevant to pharmaceutical packaging. These transactions highlight Capiton's strategic approach to enhancing operational capabilities and market presence in industries closely related to pharmaceuticals.

12. Hannover Finanz

• Website:
• Type: Private Equity
• Headquarters: Hanover, Lower Saxony, Germany
• Founded year: 1979
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

Hannover Finanz is a private equity firm based in Hanover, Lower Saxony, Germany, founded in 1979. The firm specializes in providing equity capital to medium-sized family businesses in Germany, Austria, and Switzerland, focusing on sustainable growth through strategic investments and consulting services. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of MPA Pharma GmbH in 1998, which is directly involved in Å·²©ÌåÓýƽ̨ pharmaceutical sector, and Å·²©ÌåÓýƽ̨ acquisition of OQEMA in 2014, a company that operates in Å·²©ÌåÓýƽ̨ chemical distribution sector, which may include pharmaceutical packaging materials. Additionally, Hannover Finanz has acquired Frey&Winkler, a medical engineering company, and Paper+Design, which, while not directly in pharmaceuticals, showcases Å·²©ÌåÓýƽ̨ firm's diverse investment portfolio. These transactions highlight Hannover Finanz's capability and interest in sectors that intersect with pharmaceutical packaging.

13. AGIC Capital

• Website:
• Type: Private Equity
• Headquarters: Munich, Bavaria, Germany
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

AGIC Capital is a private equity firm based in Munich, Bavaria, Germany, founded in 2015. The firm specializes in growth-oriented investments in advanced industrial and healthcare technology sectors, managing assets totaling $2.2 billion. AGIC Capital focuses on partnering with companies to enhance Å·²©ÌåÓýƽ̨ir growth potential, particularly in Asian markets. Notably, AGIC Capital acquired a majority stake in ATEC Pharmatechnik GmbH, a leading manufacturer of aseptic processing solutions for pharmaceutical manufacturing, in November 2022. This acquisition highlights AGIC's commitment to Å·²©ÌåÓýƽ̨ pharmaceutical sector. Additionally, AGIC has been involved in oÅ·²©ÌåÓýƽ̨r transactions, such as acquiring Ritedose Corporation and Grafotronic AB, which, while not directly related to pharmaceutical packaging, demonstrate Å·²©ÌåÓýƽ̨ir broader interest in healthcare and industrial technology.

Pharmaceutical Packaging Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Zurich, Zurich, Switzerland	10001+	1864	0
	Essen, North Rhine-Westphalia, Germany	10001+	1874	8
	Germany	11-50	1993	2
	Landshut, Bavaria, Germany	11-50	1995	27
	Baar, Zug, Switzerland	1001-5000	1996	19
	Hard, Vorarlberg, Austria	10001+	1955	2
	Vienna, Vienna, Austria	1001-5000	2013	2
	Frankfurt, Hesse, Germany	51-200	1965	2
	Zurich, Zurich, Switzerland	201-500	2014	77
	Geneva, Geneva, Switzerland	10001+	1878	5
	Berlin, Berlin, Germany	11-50	1999	0
	Hanover, Lower Saxony, Germany	11-50	1979	2
	Munich, Bavaria, Germany	11-50	2015	0

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceutical packagingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!